Results about: pulmonary fibrosis
A team headed by Manuel Serrano at IRB Barcelona has designed a drug encapsulation system that selectively targets senescent cells.
The study paves the way for therapeutic approaches to eliminate senescent cells in many diseases, such as pulmonary fibrosis and cancer.
The renowned scientist joins the Institute for Research in Biomedicine (IRB Barcelona) after 13 years at CNIO, funded by the “la Caixa” Banking Foundation and by the Government of Catalonia's ICREA programme.
Manuel Serrano will study how damaged tissue is repaired and search for therapies based on regenerative medicine for the treatment of diabetes and other diseases.
From cancer to tissue repair, from CNIO to IRB Barcelona